Latigo Biotherapeutics, Inc. (LTGO)
NASDAQ: LTGO · Real-Time Price · USD
20.06
+0.68 (3.51%)
At close: Aug 13, 2026, 4:00 PM EDT
20.01
-0.05 (-0.25%)
After-hours: Aug 13, 2026, 7:34 PM EDT
Latigo Biotherapeutics Market Cap
Latigo Biotherapeutics has a market cap or net worth of $1.27 billion as of August 13, 2026.
Market Cap
1.27B
Enterprise Value
1.23B
1-Year Change
n/a
Ranking
Category
Stock Price
20.06
ChartMarket Cap Chart
Since the IPO on August 7, 2026, Latigo Biotherapeutics's market cap has increased from $1.08B to $1.27B, an increase of 17.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2026 | 1.27B | 3.54% |
| Aug 12, 2026 | 1.23B | 4.62% |
| Aug 11, 2026 | 1.17B | -0.22% |
| Aug 10, 2026 | 1.17B | 8.40% |
| Aug 7, 2026 | 1.08B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Monte Rosa Therapeutics | 1.37B |
| Novavax | 1.34B |
| Alpha Tau Medical | 1.34B |
| Immatics | 1.32B |
| Aktis Oncology | 1.32B |
| Cullinan Therapeutics | 1.28B |
| Alto Neuroscience | 1.28B |
| Corvus Pharmaceuticals | 1.27B |